2022 New Zealand Melanoma Summit > Sponsors

Thank you to our sponsors

The MelNet Executive Committee would like to thank their sponsorship partners whose support has made the sixth New Zealand Melanoma Summit possible.

Become a sponsor

Sponsorship opportunities are still available. For more information please contact:

Marion Peat
Events and Communications Coordinator
Melanoma Network of New Zealand Incorporated
+64 21 139 9670

Premier Sponsors:


Gold Sponsors:

Merck Sharp & Dohme (New Zealand) Limited (MSD) is a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA. MSD was established in New Zealand in 1962.

In New Zealand, MSD provides medicines, vaccines and biologic therapies across a broad range of therapeutic areas. These include; oncology, anaesthesia, HIV/AIDS, antibacterials/antifungals and immunisations.

MSD is one of the few pharmaceutical companies still conducting clinical trials in New Zealand and as at June 2020 invested approximately $NZ78 million in local clinical research. Current research programs include oncology, infectious diseases, endocrinology, chronic cough and vaccines.